Iovance Biotherapeutics: Q4 Earnings Insights

Iovance Biotherapeutics IOVA reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Iovance Biotherapeutics missed estimated earnings by -5.0%, reporting an EPS of $-0.45 versus an estimate of $-0.43.

Revenue was up $482 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 3.0% drop in the share price the next day.

To track all earnings releases for Iovance Biotherapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.